APTULLAHOĞLU, E. Et Al. 2019. The spliceosome inhibitor E7107 induces a dose-dependent cytotoxicity in CLL cells and produces aberrantly spliced transcripts and protein products of p53 pathway genes. The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) , (Edinburgh, Saint Helena).

APTULLAHOĞLU, E., Wallis, J. P., Marr, H., Marshall, S., Willmore, E., & Lunec, J., (2019). The spliceosome inhibitor E7107 induces a dose-dependent cytotoxicity in CLL cells and produces aberrantly spliced transcripts and protein products of p53 pathway genes . The International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Edinburgh, Saint Helena

APTULLAHOĞLU, ERHAN Et Al. "The spliceosome inhibitor E7107 induces a dose-dependent cytotoxicity in CLL cells and produces aberrantly spliced transcripts and protein products of p53 pathway genes," The International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Edinburgh, Saint Helena, 2019

APTULLAHOĞLU, ERHAN Et Al. "The spliceosome inhibitor E7107 induces a dose-dependent cytotoxicity in CLL cells and produces aberrantly spliced transcripts and protein products of p53 pathway genes." The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) , Edinburgh, Saint Helena, 2019

APTULLAHOĞLU, E. Et Al. (2019) . "The spliceosome inhibitor E7107 induces a dose-dependent cytotoxicity in CLL cells and produces aberrantly spliced transcripts and protein products of p53 pathway genes." The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) , Edinburgh, Saint Helena.

@conferencepaper{conferencepaper, author={ERHAN APTULLAHOĞLU Et Al. }, title={The spliceosome inhibitor E7107 induces a dose-dependent cytotoxicity in CLL cells and produces aberrantly spliced transcripts and protein products of p53 pathway genes}, congress name={The International Workshop on Chronic Lymphocytic Leukemia (iwCLL)}, city={Edinburgh}, country={Saint Helena}, year={2019}}